Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A Single-arm Phase 2 Multicenter Study of Evorpacept in Combination with Trastuzumab and Chemotherapy in Participants with Metastatic HER2-Positive Breast Cancer'. The following are the other relevant details related to the trial:
Therapeutic Area: Oncology (including Haematology-Oncology)
Trial Centre(s):
Curie Oncology
National Cancer Centre
Trial Status: NA
Principal Investigator(s):
Dr Lynette Ngo Su-Mien
Dr Rebecca Dent
Published by HT Digital Content Services with permission from Health Daily Digest....